About
Main Sequence is a Sydney-based venture capital fund, founded in 2017, investing from pre-seed and seed through to Series A and Series B and beyond. Its recent deals span climate and energy, hardware and robotics, space and defence and AI infrastructure, and it spun out of CSIRO, Australia's national science agency, raising a $450 million third fund in 2022. Recent investments include Kinoxis Therapeutics and Avarni.
